Brooklyn ImmunoTherapeutics Inc (NYSE:BTX – Get Free Report) announced a dividend on Monday, March 3rd, NASDAQ Dividends reports. Stockholders of record on Friday, March 14th will be paid a dividend of 0.0862 per share on Monday, March 31st. The ex-dividend date is Friday, March 14th.
Brooklyn ImmunoTherapeutics Stock Down 1.0 %
Shares of BTX stock opened at $6.90 on Wednesday. The stock has a market capitalization of $405.90 million, a PE ratio of -3.04 and a beta of 4.61. The firm has a 50 day moving average of $1.61 and a two-hundred day moving average of $1.24. Brooklyn ImmunoTherapeutics has a 52 week low of $6.66 and a 52 week high of $8.31.
Analyst Ratings Changes
Separately, StockNews.com assumed coverage on Brooklyn ImmunoTherapeutics in a research report on Wednesday, February 26th. They issued a “hold” rating on the stock.
Brooklyn ImmunoTherapeutics Company Profile
Eterna Therapeutics, Inc is a clinical stage biopharmaceutical company, which engages in creating transformative regenerative medicine treatments for cancer, blood disorders, and monogenic diseases. It offers IRX-2, a human cell-derived cytokine therapy, studying the safety and efficacy of IRX-2 in patients with head and neck cancer in Phase 2B.
Featured Stories
- Five stocks we like better than Brooklyn ImmunoTherapeutics
- Trading Halts Explained
- Lemonade’s Q4 Surge: Has This AI-Powered Insurer Turned a Corner?
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- 2 Energy Stocks to Play Both Sides of Tariff Uncertainty
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Raytheon vs. Lockheed Martin: Which Stock Has More Upside?
Receive News & Ratings for Brooklyn ImmunoTherapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Brooklyn ImmunoTherapeutics and related companies with MarketBeat.com's FREE daily email newsletter.
